Riskpilot← Back to searchSign inGet full accessSCSK 2213 ApS
APSActiveCVR 20602686Rolighedsvej 14, 3. tvBuying and selling of own real estate · NACE 6811Est. 1998— employees
Revenue 2025
—
EBITDA margin
—
-1% vs 2024
Equity ratio
-88.0%
Financial strength
Net profit 2025
DKK 579K
+53% vs 2024
| Revenue | — | — |
| EBITDA | DKK -22K | -1% |
| Net profit | DKK 579K | +53% |
| Total assets | DKK 1,8M | -31% |
| Equity | DKK -1,6M | +27% |
| Employees | — | — |
Legal name
SCSK 2213 ApS
CVR number
20602686
Legal form
Anpartsselskab
NACE code
6811 · Buying and selling of own real estate
Founded
1. januar 1998
Share capital
DKK 125.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er køb, salg og udlejning af fast ejendom, import og salg af helseprodukter/pharmaceutika samt investering og finansiering og hermed beslægtet virksomhed.
Address
Rolighedsvej 14, 3. tv
Phone
+4527130307
Email
annemettelynghb@gmail.comm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | -11 | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -7 | -11 | -11 | -21 | -22 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -7 | -11 | -11 | -21 | -22 |
| Net financials | 0 | 0 | 0 | 401 | 601 |
| Profit before tax | -7 | -11 | -11 | 379 | 579 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -7 | -11 | -11 | 379 | 579 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 2.599 | 1.801 |
| Equity | -2.522 | -2.532 | -2.543 | -2.164 | -1.585 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.522 | 2.532 | 2.543 | 4.763 | 3.386 |
| Total debt | 2.522 | 2.532 | 2.543 | 4.763 | 3.386 |
EBITDA margin
-2172500.0%
This company
15.8%
Market median
-13750100% vs market
20212025
Equity ratio
-88.0%
This company
38.2%
Market median
-330% vs market
20212025
Return on equity
57887800.0%
This company
18.4%
Market median
+314607509% vs market
20212025
Net profit margin
57887800.0%
This company
8.1%
Market median
+714664098% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
2.14×
This company
0.62×
Market median
-245% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
CB Management | Management | 2003 – 2004 |
SS Management | Management | 1998 – 1998 |
CE | Audit | 1998 – 1998 |
HB Management | Management | 2004 – 2006 |
GJ Management | Management | 2000 – 2003 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 1998 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SCSK 2213 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claus Bjerregaard | Management | 0 companies |
| Steen Schierbeck | Management | 0 companies |
| Carl Edvard Gudbergsen | Audit | 0 companies |
| Henrik Bille Pedersen | Management | 0 companies |
| Grethe Jensen | Management | 0 companies |